JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
CALL
Fate Therapeutics
FATE
$294M
| $1.47M | ﹤0.01% |
+75,000
| New | +$1.19M |
|
|
NVTA
3452
DELISTED
Invitae Corporation
NVTA
| $1.46M | ﹤0.01% |
90,696
+48,634
| +116% | +$860K |
|
3453
Helios Technologies
HLIO
$2.67B
| $1.46M | ﹤0.01% |
31,572
+21,967
| +229% | +$942K |
|
3454
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $1.46M | ﹤0.01% |
28,610
+193
| +0.7% | +$9.85K |
|
|
KE
3455
Kimball Electronics
KE
$626M
| $1.46M | ﹤0.01% |
83,112
-11,951
| -13% | -$196K |
|
3456
WesBanco
WSBC
$4.1B
| $1.46M | ﹤0.01% |
38,553
+11,633
| +43% | +$434K |
|
3457
BioCryst Pharmaceuticals
BCRX
$2.51B
| $1.46M | ﹤0.01% |
422,162
-377,812
| -47% | -$950K |
|
|
CHK
3458
DELISTED
Chesapeake Energy Corporation
CHK
| $1.46M | ﹤0.01% |
8,819
-3,457
| -28% | -$695K |
|
3459
John B. Sanfilippo & Son
JBSS
$1.01B
| $1.46M | ﹤0.01% |
15,932
-5,679
| -26% | -$551K |
|
3460
Provident Financial Services
PFS
$3.26B
| $1.46M | ﹤0.01% |
59,053
-5,986
| -9% | -$148K |
|
|
ANH
3461
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $1.45M | ﹤0.01% |
412,673
+267,414
| +184% | +$925K |
|
|
VAL
3462
PUT
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $1.45M | ﹤0.01% |
+221,400
| New | +$1.08M |
|
3463
Employers Holdings
EIG
$871M
| $1.44M | ﹤0.01% |
34,393
-24,133
| -41% | -$1.02M |
|
|
TBNK
3464
DELISTED
Territorial Bancorp Inc.
TBNK
| $1.43M | ﹤0.01% |
46,351
+4,861
| +12% | +$147K |
|
|
LMNX
3465
DELISTED
Luminex Corp
LMNX
| $1.43M | ﹤0.01% |
61,596
+20,248
| +49% | +$418K |
|
3466
CALL
Crocs
CROX
$6.36B
| $1.42M | ﹤0.01% |
+34,000
| New | +$1.19M |
|
3467
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
| $1.42M | ﹤0.01% |
28,616
-5,295
| -16% | -$246K |
|
3468
CALL
Crown Holdings
CCK
$12.9B
| $1.42M | ﹤0.01% |
+19,600
| New | +$1.4M |
|
|
FLOW
3469
DELISTED
SPX FLOW, Inc.
FLOW
| $1.42M | ﹤0.01% |
29,044
-897
| -3% | -$39.8K |
|
3470
CALL
Conagra Brands
CAG
$7.39B
| $1.41M | ﹤0.01% |
41,300
-8,700
| -17% | -$252K |
|
|
NXGN
3471
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.41M | ﹤0.01% |
87,969
-23,312
| -21% | -$385K |
|
3472
GrafTech
EAF
$203M
| $1.41M | ﹤0.01% |
12,145
-7,648
| -39% | -$961K |
|
3473
Equinox Gold
EQX
$13.1B
| $1.41M | ﹤0.01% |
+182,953
| New | +$1.13M |
|
|
AVID
3474
DELISTED
Avid Technology Inc
AVID
| $1.41M | ﹤0.01% |
163,820
+97,371
| +147% | +$717K |
|
3475
Bloom Energy
BE
$69.6B
| $1.41M | ﹤0.01% |
188,147
+24,580
| +15% | +$119K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.